Hydoxycarbamide and L-Carnitine Therapy in Sickle Cell Anemia
Status:
Completed
Trial end date:
2021-07-10
Target enrollment:
Participant gender:
Summary
The role of the combination therapy of hydroxyurea and L-Carnitine was studied in thalassemic
patients. nevertheless its role in sickle cell anemia patients was not investigated